| (Values in U.S. Thousands) | Dec, 2020 | Sep, 2020 | Jun, 2020 | Mar, 2020 | Dec, 2019 |
| Sales | 9,340 | 2,320 | 0 | 0 | 30,000 |
| Sales Growth | +302.59% | unch | unch | -100.00% | unch |
| Net Income | -33,390 | -37,650 | -38,860 | -40,780 | -11,570 |
| Net Income Growth | +11.31% | +3.11% | +4.71% | -252.46% | +76.10% |
Viela Bio Inc (VIE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Viela Bio Inc. is a clinical-stage biotechnology company pioneering treatments for autoimmune and severe inflammatory diseases. Viela Bio Inc. is headquartered in Gaithersburg, Maryland.
Fiscal Year End Date: 12/31